Boston Partners
TARO

Boston Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Boston Partners’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14,643
Closed -$1.24M – 738
2018
Q4 		$1.24M Sell
14,643
-8,258
-36% -$796K ﹤0.01% 620
2018
Q3 		$2.25M Sell
22,901
-640
-3% -$69.3K ﹤0.01% 590
2018
Q2 		$2.72M Buy
+23,541
New +$2.59M ﹤0.01% 604
2016
Q3 		– Sell
-11,503
Closed -$1.68M – 770
2016
Q2 		$1.68M Buy
11,503
+931
+9% +$132K ﹤0.01% 662
2016
Q1 		$1.51M Hold
10,572
– – ﹤0.01% 649
2015
Q4 		$1.63M Buy
+10,572
New +$1.54M ﹤0.01% 637

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.28B AUM 21.14% 1-Year Est. Return